TORONTO--(BUSINESS WIRE)--Aug. 10, 2009-- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the Canaccord Adams Global Growth Conference at the Intercontinental Boston hotel in Boston, MA.
Biovail’s presentation is scheduled for Thursday, August 13, 2009 at 8:30 a.m. EDT. A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail’s Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
Source: Biovail Corporation
Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice President, Investor Relations & Corporate Communications
